buprenorphine 2 MG / naloxone 0.5 MG Buccal Film
- RxCUI
- 1010600
- RxNorm name
- buprenorphine 2 MG / naloxone 0.5 MG Buccal Film
- Display name
- buprenorphine 2 MG / naloxone 0.5 MG Buccal Film
- Full name
- buprenorphine 2 MG / naloxone 0.5 MG Buccal Film
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:07
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Buprenorphine and Naloxone | BUPRENORPHINE AND NALOXONE | Redpharm Drug | 5005a6c8-9a3b-a99a-e063-6294a90aac13 | 2026-04-22 | Warnings, Adverse reactions | 1010600 |
| Buprenorphine and Naloxone | BUPRENORPHINE AND NALOXONE | Aveva Drug Delivery Systems Inc. | cb112448-49a1-4209-bcdb-7cfae6501f51 | 2026-04-07 | Warnings, Adverse reactions | 1010600 |
| Buprenorphine and Naloxone | BUPRENORPHINE AND NALOXONE | INGENUS PHARMACEUTICALS, LLC | 4951ec29-609b-4836-b0e4-0d9c1d6ae6fe | 2026-03-23 | Warnings, Adverse reactions | 1010600 |
| Buprenorphine and Naloxone | BUPRENORPHINE AND NALOXONE | Redpharm Drug | 300ae3d0-464c-d0be-e063-6294a90a7f9d | 2026-02-21 | Warnings, Adverse reactions | 1010600 |
| Buprenorphine and Naloxone | BUPRENORPHINE AND NALOXONE | Camber Pharmaceuticals, Inc. | 221195e4-de08-414c-af08-a611a74789de | 2026-01-30 | Warnings, Adverse reactions | 1010600 |
| Buprenorphine and Naloxone | BUPRENORPHINE AND NALOXONE | Mylan Pharmaceuticals Inc. | 557d8d4d-8751-431c-b18e-9d5cf23fc579 | 2026-01-15 | Warnings, Adverse reactions | 1010600 |
| Buprenorphine and Naloxone | BUPRENORPHINE AND NALOXONE | Dr.Reddys Laboratories Inc | 718756d7-0131-b173-6c45-5ee039b311b0 | 2026-01-12 | Warnings, Adverse reactions | 1010600 |
| Buprenorphine and Naloxone Sublingual Film | BUPRENORPHINE AND NALOXONE | Alvogen Inc. | 4210afeb-474c-d842-d68e-af7e0021851a | 2026-01-01 | Warnings, Adverse reactions | 1010600 |
| Suboxone | BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE | INDIVIOR INC. | 8a5edcf9-828c-4f97-b671-268ab13a8ecd | 2025-12-22 | Warnings, Adverse reactions | 1010600 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 8a5edcf9-828c-4f97-b671-268ab13a8ecd | buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual Film [PSN] · buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [SCD] · buprenorphine 2 MG / naloxone 0.5 MG Buccal Film [SY] · buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [SY] | 4 | 37 | These highlights do not include all the information needed to use SUBOXONE sublingual film safely and effectively. See full prescribing information for SUBOXONE sublingual film. SUBOXONE ® (buprenorphine and naloxone) sublingual film, for sublingual or buccal use, CIII Initial U.S. Approval: 2002 | 20251222 |
| 4210afeb-474c-d842-d68e-af7e0021851a | buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual Film [PSN] · buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [SCD] · buprenorphine 2 MG / naloxone 0.5 MG Buccal Film [SY] · buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [SY] | 4 | 19 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM. BUPRENORPHINE and NALOXONE sublingual film, for sublingual or buccal use, CIII Initial U.S. Approval: 2002 | 20260101 |
| 557d8d4d-8751-431c-b18e-9d5cf23fc579 | buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual Film [PSN] · buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [SCD] · buprenorphine 2 MG / naloxone 0.5 MG Buccal Film [SY] · buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [SY] | 4 | 12 | These highlights do not include all the information needed to use BUBRENORPHINE AND NALOXONE SUBLINGUAL FILM safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM. BUPRENORPHINE and NALOXONE sublingual film, for sublingual or buccal use CIII Initial U.S. Approval: 2002 | 20260115 |
| 718756d7-0131-b173-6c45-5ee039b311b0 | buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual Film [PSN] · buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [SCD] · buprenorphine 2 MG / naloxone 0.5 MG Buccal Film [SY] · buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [SY] | 4 | 10 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM. BUPRENORPHINE and NALOXONE sublingual film, for sublingual or buccal use CIII Initial U.S. Approval: 2002 | 20260112 |
| 4951ec29-609b-4836-b0e4-0d9c1d6ae6fe | buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual Film [PSN] · buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [SCD] · buprenorphine 2 MG / naloxone 0.5 MG Buccal Film [SY] · buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [SY] | 4 | 6 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM. BUPRENORPHINE and NALOXONE sublingual film, for sublingual or buccal use, CIII Initial U.S. Approval: 2002 | 20260323 |
| 300ae3d0-464c-d0be-e063-6294a90a7f9d | buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual Film [PSN] · buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [SCD] · buprenorphine 2 MG / naloxone 0.5 MG Buccal Film [SY] · buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [SY] | 4 | 4 | These highlights do not include all the information needed to use BUBRENORPHINE AND NALOXONE SUBLINGUAL FILM safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM. BUPRENORPHINE and NALOXONE sublingual film, for sublingual or buccal use CIII Initial U.S. Approval: 2002 | 20260221 |
| cb112448-49a1-4209-bcdb-7cfae6501f51 | buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual Film [PSN] · buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [SCD] · buprenorphine 2 MG / naloxone 0.5 MG Buccal Film [SY] · buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [SY] | 4 | 2 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM. BUPRENORPHINE and NALOXONE sublingual film, for sublingual or buccal use, CIII Initial U.S. Approval: 2002 | 20260407 |
| 5005a6c8-9a3b-a99a-e063-6294a90aac13 | buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual Film [PSN] · buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [SCD] · buprenorphine 2 MG / naloxone 0.5 MG Buccal Film [SY] · buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [SY] | 4 | 1 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM. BUPRENORPHINE and NALOXONE sublingual film, for sublingual or buccal use, CIII Initial U.S. Approval: 2002 | 20260422 |
| 221195e4-de08-414c-af08-a611a74789de | buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual Film [PSN] · buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [SCD] · buprenorphine 2 MG / naloxone 0.5 MG Buccal Film [SY] · buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film [SY] | 4 | 1 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM. BUPRENORPHINE and NALOXONE sublingual film, for sublingual or buccal use, CIII Initial U.S. Approval: 2002 | 20260130 |